Consumers' knowledge about the importance of well-being and disease prevention increases with the rising availability and application of online medicine portals and health organization websites for consultation. They have become more health-conscious and taking a proactive approach to disease treatment and prevention. Moreover, the growing popularity of fitness, bodybuilding, and specialist sports ("from health to fit") among people aged between 20 and 40 is boosting the need for diet pills and supplements that help them achieve their aesthetic goals and improve their performance. The number of gym and fitness enthusiasts has increased rapidly in the last decade. Several fitness coaches and professionals recommend the intake of diet pills for weight loss. Diet pill industry players across North America are likely to introduce new varieties of diet pills in the next decade.
With the new features and technologies, vendors attract new customers to grow their footprints in emerging markets. This factor is likely to drive the North America Diet Pills market. The North America Diet Pills market is expected to grow at a substantial CAGR during the forecast period.
The North America diet pills market is segmented into product type, application, age group, distribution channel, and country. Based on product type, the North America diet pills market is segmented into prescription, herbal supplements, and over the counter drugs. The prescription segment dominated the market in 2020. Based on application, the North America diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. The appetite suppression segment led the market in 2020. Based on age group, the North America diet pills market is bifurcated into adults and teenagers. The adults segment dominated the market in 2020. Based on distribution channel, the North America diet pills market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies & drug stores. The hospital pharmacies segment led the market in 2020. Based on country, the North America diet pills market is segmented into the US, Canada, and Mexico. The US segment dominated the market in 2020.
Pfizer Inc. (Arena Pharmaceutical GMBH), Novo Nordisk A/S, Gelesis, VIVUS LLC, GlaxoSmithKline plc, Lovate Health Sciences International Inc., TEVA Pharmaceutical Industries LTD, Currax Pharmaceutical LLC, Chong’s Health Care, and Zoller Laboratories are among the leading companies operating in the North America Diet Pills market..
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 466.95 Million |
| Market Size by 2028 | US$ 949.03 Million |
| CAGR (2021 - 2028) | 10.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Diet Pills Market is valued at US$ 466.95 Million in 2021, it is projected to reach US$ 949.03 Million by 2028.
As per our report North America Diet Pills Market, the market size is valued at US$ 466.95 Million in 2021, projecting it to reach US$ 949.03 Million by 2028. This translates to a CAGR of approximately 10.7% during the forecast period.
The North America Diet Pills Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Diet Pills Market report:
The North America Diet Pills Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Diet Pills Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Diet Pills Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)